| 01/26 | FDA advisers back the same COVID vaccine for initial shots, boosters | RE |
| 01/26 | Novavax needs 6 months to produce annual COVID shots that match new variants | RE |
| 01/25 | Novavax Announces Grant of Inducement Awards Pursuant to Nasdaq Listing Rule 5635(c)(4) | PR |
| 01/20 | River Private Wealth announces new round of investment in Novavax, Inc | AQ |
| 01/20 | Novavax, Inc. announced that it has received $6.75 million in funding from River Privat.. | CI |
| 01/18 | Novavax Says South Korea Partner Obtained Approval for Use of COVID-19 Vaccine as Adult.. | MT |
| 01/18 | Novavax COVID-19 Jab Gets South Korea's OK as Booster for Adults | MT |
| 01/18 | Novavax Nuvaxovid COVID-19 Vaccine Approved in South Korea as an Adult Booster | PR |
| 01/10 | MarketScreener's World Press Review: January 10 | |
| 01/10 | North American Morning Briefing: More Hawkish Fed -2- | DJ |
| 01/09 | Transcript : Novavax, Inc. Presents at 41st Annual J.P. Morgan Healthcare Con.. | CI |
| 01/09 | Novavax's longtime CEO Stanley Erck to retire | RE |
| 01/09 | Novavax Appoints John Jacobs as CEO | MT |
| 01/09 | Novavax's longtime CEO Stanley Erck to retire | RE |
| 01/09 | Novavax Names John C. Jacobs as New President & Chief Executive Officer | PR |
| 01/09 | Novavax, Inc. Announces Management Changes | CI |
| 01/09 | Novavax, Inc. Announces Chief Executive Officer Changes | CI |
| 01/09 | Novavax CEO Stanley Erck to retire | RE |
| 01/09 | Novavax : to Participate in the 41st Annual J.P. Morgan Healthcare Conference | PU |
| 01/09 | B. Riley Lowers Novavax's Price Target to $37 From $74, Keeps Buy Rating | MT |
| 2022 | Novavax Initiates Phase 2 Trial for COVID-19-Influenza Combination, Stand-Alone Influen.. | MT |
| 2022 | Novavax Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination and St.. | PR |
| 2022 | Novavax, Inc. Announces Initiation of Phase 2 Trial for COVID-19-Influenza Combination .. | CI |
| 2022 | Novavax Completes Offerings of Common Shares, Convertible Notes for Gross Proceeds of $.. | MT |
| 2022 | Novavax Announces Closing of $175.25 Million Offering of Convertible Senior Notes Due 2.. | PR |
| 2022 | Analysis-Short sellers gain nearly $304 billion after tumble .. | RE |
| 2022 | Novavax to Start Influenza's Phase 2 CIC Trial by 2022 End | MT |
| 2022 | German Health Authority Expands Recommendation for Use of Novavax COVID-19 Vaccine as a.. | AQ |
| 2022 | Novavax Receives Expanded Recommendation For COVID-19 Vaccine From Germany | MT |
| 2022 | Sector Update: Health Care Stocks Stumble on Friday | MT |
| 2022 | Sector Update: Health Care Stocks Lose Ground in Friday Trading | MT |
| 2022 | Sector Update: Health Care | MT |
| 2022 | Comanche Biopharma Announces Appointment of Allison August, M.D., as Chief Medical Offi.. | AQ |
| 2022 | Sector Update: Health Care Stocks Mixed Premarket Friday | MT |
| 2022 | Weak Retail Spending, Recession Fears Expected to Continue Weighing on US Equities | MT |
| 2022 | Sector Update: Health Care | MT |
| 2022 | Novavax Prices $150 Million Senior Notes Offering, $65 Million Common Stock Offering | MT |
| 2022 | Novavax Announces Pricing of $150 Million Offering of Convertible Senior Notes | AQ |
| 2022 | Novavax Announces Pricing of $65 Million Public Offering of Common Stock | PR |
| 2022 | Novavax Announces Pricing of $65 Million Public Offering of Common Stock | AQ |
| 2022 | Novavax Announces Pricing of $150 Million Offering of Convertible Senior Notes | PR |
| 2022 | Novavax's Shares Drop 37% After Cut In COVID-19 Vaccine Supplies To UK | MT |
| 2022 | Nordson, AbCellera rise; Warner Bros., Novavax fall | AQ |
| 2022 | Top Midday Decliners | MT |
| 2022 | Novavax Down 26% After Announcing Stock and Convertible Note Sales | DJ |
| 2022 | Global markets live: HSBC, Tesla, Microsoft, Blackstone, Serco... | |
| 2022 | No Christmas rally this year? | |
| 2022 | Sector Update: Health Care Stocks Mixed Premarket Thursday | MT |
| 2022 | North American Morning Briefing: Rough Start For Futures.. | DJ |
| 2022 | Novavax, Inc. Reaffirms Revenue Guidance for the Full Year 2022 | CI |
| 2022 | Novavax Plans $125 Million Common-Stock Offering, $125 Million Debt Offering; Shares De.. | MT |
| 2022 | Novavax Announces Proposed Offering of $125 Million of Convertible Senior Notes | PR |
| 2022 | Novavax Announces Proposed $125 Million Public Offering of Common Stock | PR |
| 2022 | Novavax Secures Expanded Use for COVID-19 Booster in Switzerland, France | MT |
| 2022 | Novavax : Swiss and French Health Authorities Expand Recommendations for Use of Nuvaxovid .. | PU |
| 2022 | Novavax, Inc. Appoints Richard J. Rodgers as Member of Its Audit Committee and as A Mem.. | CI |
| 2022 | French Public Health Body Snubs Valneva in COVID-19 Vaccine Strategy | MT |
| 2022 | Valneva shares fall as French health body advises against its COVID-19 vaccine | RE |
| 2022 | Novavax's COVID-19 Jab Gets Canadian Approval for Adolescents | MT |
| 2022 | Novavax Covid-19 Vaccine Gets Health Canada Approval for Adolescents | DJ |
| 2022 | Novavax Says Canadian Regulator Approves Nuvaxovid COVID-19 Vaccine for Adolescents | MT |
| 2022 | Canada OKs Novavax's Covid Vaccine for Adolescents Aged 12-17 | MT |
| 2022 | Novavax, Inc. Announces Nuvaxovid COVID-19 Vaccine Approval in Canada for Use as a Prim.. | CI |
| 2022 | Novavax Nuvaxovid COVID-19 Vaccine Approved in Canada for Use as a Primary Series in Ad.. | PR |
| 2022 | Transcript : Novavax, Inc. Presents at Bank of America 2022 Virtual Biotech S.. | CI |
| 2022 | Novavax to Participate in BofA Securities 2022 Virtual Biotech SMID Cap Conference | AQ |
| 2022 | Novavax to Participate in BofA Securities 2022 Virtual Biotech SMID Cap Conference | PR |
| 2022 | TRADING UPDATES: XLMedia, Mobile Streams and Windar win deals | AN |
| 2022 | Novavax Says WHO Updates Emergency Use Listing for Its COVID-19 Vaccine | MT |
| 2022 | World Health Organization Updates Emergency Use Listing for Novavax Nuvaxovid COVID-19 .. | PR |
| 2022 | Novavax, Inc. Announces the World Health Organization Issue an Updated Emergency Use Li.. | CI |
| 2022 | Novavax - Termination of COVID-19 Vaccine Purchase Agreement with Gavi | AQ |
| 2022 | GAVI Alliance Refutes Novavax's Claims Of Breaching COVID-19 Vaccine Purchase Deal | MT |
| 2022 | Gavi rejects Novavax's claim on COVID vaccine deal breach | RE |
| 2022 | Gavi says it is not in breach of Novavax vaccine deal | RE |
Google
Twitter
Facebook
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
